Skip to content
VICI Healthcare

Leukemia CLL – Rai Stage III-IV

Reviewed by Oncology Team, VICI Healthcare | Last updated: 2026-04

2-5 years without therapy

5-year survival rate

CLL – Rai Stage III-IV

Anemia (Hb <11 g/dL), thrombocytopenia (<100K), with or without lymphadenopathy

What CLL – Rai Stage III-IV Means

Anemia (Hb <11 g/dL), thrombocytopenia (<100K), with or without lymphadenopathy

Treatment Approach for CLL – Rai Stage III-IV

Chemoimmunotherapy (rituximab + fludarabine) or venetoclax-based regimens; consider HSCT for fit patients

Survival Rates and Prognosis

The 5-year survival rate for leukemia at CLL – Rai Stage III-IV is approximately 2-5 years without therapy. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.

Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.

How Other Stages Compare

Stage 5-Year Survival Treatment
ALL – Low Risk 80-90% 5-year event-free survival Standard induction + consolidation + maintenance (2.5-3 years); CNS prophylaxis…
ALL – High Risk 40-60% 5-year event-free survival Intensified chemotherapy + TKI (if BCR-ABL+) + consideration of allogeneic HSCT
AML – Favorable 70-80% 5-year overall survival 7+3 induction ± high-dose cytarabine; ATRA + arsenic for APL; selective HSCT…
AML – Intermediate 40-60% 5-year overall survival 7+3 or lower-intensity induction based on age/fitness; standard post-remission…
AML – Unfavorable 5-20% 5-year overall survival Consider lower-intensity chemotherapy, hypomethylating agents (azacitidine), or…
CML – Chronic Phase >20 years with TKI monotherapy First-line TKI (imatinib 400mg, dasatinib 100mg, or nilotinib 300mg daily);…
CML – Accelerated Phase 2-3 years median Second or third-line TKI; early HSCT consideration; close MRD monitoring
CML – Blast Crisis 3-6 months without HSCT Induction chemotherapy + TKI + urgent HSCT; ponatinib for T315I mutations
CLL – Rai Stage 0 8-10 years median Watch-and-wait; defer therapy until symptomatic progression

Leukemia Treatment in Top Cities

Diagnosed with CLL – Rai Stage III-IV Leukemia?

Our specialists can review your reports and create a personalised treatment plan.

Get a Free Consultation

All Leukemia stages Leukemia overview

VICI Healthcare is for informational purposes only and does not replace professional medical advice. Always consult a qualified oncologist.

Book an Appointment

We respond within 24 hours, Mon–Sat — no cost, no obligation.

Call Us Book an Appointment